Finance

Lists
Why is ENTX down 5.14%?
Dive Deeper
ENTX:NASDAQ
Entera Bio Ltd
$2.95
-5.14%
(-0.16) 1D
Nov 5, 12:32:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENTX...
Open
$3.07
High
$3.10
Low
$2.90
Mkt. cap
513.07M
Avg. vol.
547.56K
Volume
102.75K
52-wk high
$4.20
52-wk low
$0.91
EPS
-$0.35
Beta
1.48
Shares outstanding
173.92M
No. of employees
21
Open
$3.07
High
$3.10
Low
$2.90
Mkt. cap
513.07M
Avg. vol.
547.56K
Volume
102.75K
52-wk high
$4.20
52-wk low
$0.91
EPS
-$0.35
Beta
1.48
Shares outstanding
173.92M
No. of employees
21
News stories
From web sources and news partners
About Entera Bio Ltd
CEO-
Employees21
Founded2009
Headquarters-
SectorBiotechnology
Industry-
Websiteenterabio.com
Analyst ratings
Based on 4 analysts giving stock ratings to ENTX in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ENTX in the last 3 months.
Highest
Current $2.95
$11.00 (+272.88%)
Average
$10.00 (+238.98%)
Lowest
$9.00 (+205.08%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vamil Divan
Guggenheim
Buy
Initiated
$11.00
+272.9%
09/24/2026
Patrick Dolezal
LifeSci Capital
Buy
Initiated
$10.00
+239%
09/23/2026
Imogen Mansfield
Cantor Fitzgerald
Buy
Initiated
-
-
09/22/2026
David Risinger
Leerink Partners
Buy
Initiated
$9.00
+205.1%
09/18/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$9.00
+205.1%
06/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.64M
1.72M
2.25M
3.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.61M
1.32M
1.29M
1.36M
Operating expense
3.26M
3.04M
3.54M
4.56M
Total operating expenses
3.26M
3.04M
3.54M
4.56M
Operating income
-3.26M
-3.04M
-3.54M
-4.56M
Other non operating income
-
-
-
-
EBT including unusual items
-3.20M
-3.02M
-3.50M
-7.31M
EBT excluding unusual items
-3.20M
-3.02M
-3.50M
-7.31M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.20M
-3.02M
-3.50M
-7.31M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
56.00K
26.00K
34.00K
-
Interest expense
-
-
-
-2.75M
Net interest expenses
56.00K
26.00K
34.00K
-2.75M
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.25M
-3.04M
-3.53M
-4.55M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps